(-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 epigallocatechin gallate inhibits the reaction [Paraquat results in increased expression of DIABLO protein] CTD PMID:17936647 (-)-epigallocatechin 3-gallate affects localization ISO RGD:1322043 6480464 epigallocatechin gallate analog affects the localization of DIABLO protein CTD PMID:16115949 (R,R,R)-alpha-tocopherol affects localization ISO RGD:1322044 6480464 alpha-Tocopherol affects the localization of DIABLO protein CTD PMID:15582575 1,2-dimethylhydrazine multiple interactions ISO RGD:1322044 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of DIABLO mRNA] CTD PMID:22206623 1,2-dimethylhydrazine increases expression ISO RGD:1322044 6480464 1, 2-Dimethylhydrazine results in increased expression of DIABLO mRNA CTD PMID:22206623 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1322043 6480464 2 more ... CTD PMID:27589474 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1322044 6480464 Tetrachlorodibenzodioxin affects the expression of DIABLO mRNA CTD PMID:20702594 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of DIABLO mRNA CTD PMID:33387578 2,3,7,8-Tetrachlorodibenzofuran affects expression ISO RGD:1322044 6480464 2 more ... CTD PMID:20702594 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of DIABLO mRNA CTD PMID:21346803 2,6-di-tert-butyl-4-methylphenol multiple interactions EXP 6480464 Butylated Hydroxytoluene inhibits the reaction [ganglioside more ... CTD PMID:14987999 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of DIABLO mRNA CTD PMID:21346803 2-methylcholine affects expression ISO RGD:1322043 6480464 beta-methylcholine affects the expression of DIABLO mRNA CTD PMID:21179406 3-phenylprop-2-enal multiple interactions ISO RGD:1322043 6480464 Vitamin E inhibits the reaction [cinnamaldehyde affects the localization of DIABLO protein] CTD PMID:15566391 3-phenylprop-2-enal affects localization ISO RGD:1322043 6480464 cinnamaldehyde affects the localization of DIABLO protein CTD PMID:15566391 4,4'-sulfonyldiphenol increases expression ISO RGD:1322044 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of DIABLO mRNA CTD PMID:31881267 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of DIABLO mRNA CTD PMID:36041667 4,4'-sulfonyldiphenol decreases expression ISO RGD:1322043 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of DIABLO protein CTD PMID:31945527 4-nitrophenol decreases expression ISO RGD:1322044 6480464 4-nitrophenol results in decreased expression of DIABLO mRNA CTD PMID:34673133 5-fluorouracil increases response to substance ISO RGD:1322043 6480464 DIABLO protein results in increased susceptibility to Fluorouracil CTD PMID:18031615 5-fluorouracil increases expression ISO RGD:1322043 6480464 Fluorouracil results in increased expression of DIABLO mRNA CTD PMID:16557594 6-bromoindirubin-3'-oxime multiple interactions ISO RGD:1322043 6480464 6-bromoindirubin-3'-oxime promotes the reaction [sorafenib affects the localization of DIABLO protein] CTD PMID:17991738 acetylsalicylic acid decreases expression ISO RGD:1322043 6480464 Aspirin results in decreased expression of DIABLO protein CTD PMID:15976387 adenosine increases expression ISO RGD:1322043 6480464 Adenosine results in increased expression of DIABLO mRNA, Adenosine results in increased expression of DIABLO protein CTD PMID:20063052 adenosine multiple interactions ISO RGD:1322043 6480464 Dipyridamole inhibits the reaction [Adenosine results in increased expression of DIABLO mRNA], Dipyridamole inhibits the reaction [Adenosine results in increased expression of DIABLO protein] CTD PMID:20063052 aldehydo-D-glucose multiple interactions ISO RGD:1322043 6480464 [Glucose co-treated with Deferoxamine] results in increased expression of DIABLO mRNA, Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of DIABLO mRNA] CTD PMID:33962019 aldehydo-D-glucose increases expression ISO RGD:1322043 6480464 Glucose results in increased expression of DIABLO mRNA CTD PMID:33962019 all-trans-retinoic acid multiple interactions ISO RGD:1322043 6480464 [Tretinoin co-treated with Paclitaxel] affects the localization of DIABLO protein more ... CTD PMID:17701358 more ... all-trans-retinoic acid increases expression ISO RGD:1322043 6480464 Tretinoin results in increased expression of DIABLO protein CTD PMID:17701358 alvocidib affects localization ISO RGD:1322043 6480464 alvocidib affects the localization of DIABLO protein CTD PMID:12517783 alvocidib multiple interactions ISO RGD:1322043 6480464 [alvocidib co-treated with Bortezomib] results in increased secretion of DIABLO protein more ... CTD PMID:12231544 more ... ammonium chloride increases expression EXP 6480464 Ammonium Chloride results in increased expression of DIABLO protein CTD PMID:16483693 aristolochic acid A increases expression ISO RGD:1322043 6480464 aristolochic acid I results in increased expression of DIABLO mRNA CTD PMID:33212167 arsenite(3-) decreases expression ISO RGD:1322044 6480464 arsenite results in decreased expression of DIABLO mRNA CTD PMID:33053406 arsenite(3-) multiple interactions ISO RGD:1322043 6480464 arsenite promotes the reaction [G3BP1 protein binds to DIABLO mRNA] CTD PMID:32406909 arsenous acid multiple interactions ISO RGD:1322043 6480464 [Arsenic Trioxide co-treated with Curcumin] results in increased expression of DIABLO protein CTD PMID:27430728 aspartame multiple interactions ISO RGD:1322044 6480464 [Fats more ... CTD PMID:23783067 bisphenol A increases expression ISO RGD:1322043 6480464 bisphenol A results in increased expression of DIABLO mRNA CTD PMID:25047013 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of DIABLO mRNA CTD PMID:36041667 bisphenol A multiple interactions ISO RGD:1322043 6480464 [[ginger extract results in increased abundance of Oils, Volatile] which co-treated with bisphenol A] affects the expression of DIABLO protein CTD PMID:33376534 bisphenol A decreases expression ISO RGD:1322043 6480464 bisphenol A results in decreased expression of DIABLO mRNA CTD PMID:29275510 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of DIABLO mRNA CTD PMID:25181051 Bisphenol A diglycidyl ether affects localization ISO RGD:1322043 6480464 2, 2-bis(4-glycidyloxyphenyl)propane affects the localization of DIABLO protein CTD PMID:12788809 Bisphenol B increases expression ISO RGD:1322043 6480464 bisphenol B results in increased expression of DIABLO protein CTD PMID:34186270 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of DIABLO mRNA CTD PMID:36041667 bortezomib affects localization ISO RGD:1322043 6480464 Bortezomib affects the localization of DIABLO protein CTD PMID:16024631 bortezomib increases localization ISO RGD:1322043 6480464 Bortezomib results in increased localization of DIABLO protein CTD PMID:14555532 bortezomib increases expression ISO RGD:1322043 6480464 Bortezomib results in increased expression of DIABLO mRNA, Bortezomib results in increased expression of DIABLO protein CTD PMID:17327374 , PMID:25913414 bortezomib multiple interactions ISO RGD:1322043 6480464 [alvocidib co-treated with Bortezomib] results in increased secretion of DIABLO protein more ... CTD PMID:12893773 more ... Butylparaben increases expression ISO RGD:1322043 6480464 butylparaben results in increased expression of DIABLO mRNA CTD PMID:24481588 cadmium atom multiple interactions ISO RGD:1322043 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DIABLO mRNA CTD PMID:35301059 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of DIABLO mRNA CTD PMID:21297351 cadmium dichloride multiple interactions ISO RGD:1322043 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DIABLO mRNA CTD PMID:35301059 cannabidiol affects localization ISO RGD:1322043 6480464 Cannabidiol affects the localization of DIABLO protein CTD PMID:31699976 cannabidiol multiple interactions ISO RGD:1322043 6480464 [Cannabidiol co-treated with moringin] results in decreased expression of DIABLO mRNA more ... CTD PMID:30096889 , PMID:31699976 cannabidiol decreases expression ISO RGD:1322043 6480464 Cannabidiol results in decreased expression of DIABLO mRNA CTD PMID:27714895 cannabidiol increases expression ISO RGD:1322043 6480464 Cannabidiol results in increased expression of DIABLO protein CTD PMID:31699976 cerivastatin increases localization ISO RGD:1322043 6480464 cerivastatin results in increased localization of DIABLO protein CTD PMID:15705602 chromium(6+) affects localization ISO RGD:1322043 6480464 chromium hexavalent ion affects the localization of DIABLO protein CTD PMID:16166740 chromium(6+) multiple interactions ISO RGD:1322043 6480464 TP53 protein affects the reaction [chromium hexavalent ion affects the localization of DIABLO protein] CTD PMID:16166740 chrysazin increases expression ISO RGD:1322043 6480464 danthron results in increased expression of DIABLO protein CTD PMID:21126053 cinchocaine multiple interactions EXP 6480464 Dibucaine inhibits the reaction [Paraquat affects the localization of DIABLO protein] CTD PMID:25947082 cisplatin increases response to substance ISO RGD:1322043 6480464 DIABLO protein results in increased susceptibility to Cisplatin CTD PMID:18031615 , PMID:21204765 cladribine multiple interactions ISO RGD:1322043 6480464 Cladribine promotes the reaction [Bendamustine Hydrochloride results in increased localization of DIABLO protein] CTD PMID:12948851 clobetasol decreases expression ISO RGD:1322044 6480464 Clobetasol results in decreased expression of DIABLO mRNA CTD PMID:27462272 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DIABLO mRNA CTD PMID:17602206 corosolic acid decreases expression ISO RGD:1322043 6480464 corosolic acid results in decreased expression of DIABLO mRNA, corosolic acid results in decreased expression of DIABLO protein CTD PMID:28506699 curcumin affects localization ISO RGD:1322044 6480464 Curcumin affects the localization of DIABLO protein CTD PMID:17277231 curcumin multiple interactions ISO RGD:1322043 6480464 [arsenic trioxide co-treated with Curcumin] results in increased expression of DIABLO protein CTD PMID:27430728 curcumin increases expression ISO RGD:1322043 6480464 Curcumin results in increased expression of DIABLO mRNA CTD PMID:23555722 curcumin increases response to substance ISO RGD:1322044 6480464 DIABLO protein results in increased susceptibility to Curcumin CTD PMID:17277231 cyclosporin A multiple interactions EXP 6480464 Cyclosporine inhibits the reaction [Paraquat affects the localization of DIABLO protein] CTD PMID:25947082 cylindrospermopsin increases expression ISO RGD:1322043 6480464 cylindrospermopsin results in increased expression of DIABLO mRNA CTD PMID:23726867 cyproconazole increases expression EXP 6480464 cyproconazole results in increased expression of DIABLO mRNA CTD PMID:29038839 cyproconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole] results in increased expression of DIABLO mRNA CTD PMID:29038839 D-glucose increases expression ISO RGD:1322043 6480464 Glucose results in increased expression of DIABLO mRNA CTD PMID:33962019 D-glucose multiple interactions ISO RGD:1322043 6480464 [Glucose co-treated with Deferoxamine] results in increased expression of DIABLO mRNA, Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of DIABLO mRNA] CTD PMID:33962019 desferrioxamine B increases expression ISO RGD:1322043 6480464 Deferoxamine results in increased expression of DIABLO mRNA CTD PMID:33962019 desferrioxamine B multiple interactions ISO RGD:1322043 6480464 [Glucose co-treated with Deferoxamine] results in increased expression of DIABLO mRNA, Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of DIABLO mRNA] CTD PMID:33962019 dexamethasone affects localization ISO RGD:1322043 6480464 Dexamethasone affects the localization of DIABLO protein CTD PMID:12855565 dexamethasone multiple interactions ISO RGD:1322043 6480464 [GCS-100 co-treated with Dexamethasone] affects the localization of DIABLO protein CTD PMID:16166312 diallyl disulfide decreases localization ISO RGD:1322043 6480464 diallyl disulfide results in decreased localization of DIABLO protein CTD PMID:17647244 Diallyl sulfide decreases localization ISO RGD:1322043 6480464 allyl sulfide results in decreased localization of DIABLO protein CTD PMID:17647244 diarsenic trioxide multiple interactions ISO RGD:1322043 6480464 [Arsenic Trioxide co-treated with Curcumin] results in increased expression of DIABLO protein CTD PMID:27430728 diazinon affects expression EXP 6480464 Diazinon affects the expression of DIABLO mRNA CTD PMID:22546817 dibenziodolium multiple interactions EXP 6480464 diphenyleneiodonium inhibits the reaction [Paraquat affects the localization of DIABLO protein] CTD PMID:25947082 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of DIABLO mRNA CTD PMID:22546817 diepoxybutane increases expression ISO RGD:1322043 6480464 diepoxybutane results in increased expression of DIABLO mRNA CTD PMID:29792945 dioscin increases expression ISO RGD:1322043 6480464 dioscin results in increased expression of DIABLO mRNA CTD PMID:29990575 dioxygen multiple interactions ISO RGD:1322043 6480464 3-hydroxy-4-pentenoic acid promotes the reaction [Oxygen deficiency results in increased secretion of DIABLO protein] CTD PMID:17671207 dipyridamole multiple interactions ISO RGD:1322043 6480464 Dipyridamole inhibits the reaction [Adenosine results in increased expression of DIABLO mRNA], Dipyridamole inhibits the reaction [Adenosine results in increased expression of DIABLO protein] CTD PMID:20063052 dorsomorphin multiple interactions ISO RGD:1322043 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DIABLO mRNA CTD PMID:27188386 doxorubicin increases expression ISO RGD:1322043 6480464 Doxorubicin results in increased expression of DIABLO mRNA CTD PMID:17521628 , PMID:33507000 doxorubicin multiple interactions ISO RGD:1322043 6480464 [Doxorubicin co-treated with Melatonin] results in increased expression of DIABLO protein, Doxorubicin promotes the reaction [Melatonin results in increased expression of DIABLO mRNA] CTD PMID:33507000 Echinocystic acid affects localization ISO RGD:1322043 6480464 echinocystic acid analog affects the localization of DIABLO protein CTD PMID:15863893 entinostat multiple interactions ISO RGD:1322043 6480464 [fludarabine co-treated with entinostat] results in increased secretion of DIABLO protein CTD PMID:15059916 epichlorohydrin decreases expression ISO RGD:1322043 6480464 Epichlorohydrin results in decreased expression of DIABLO mRNA CTD PMID:29792945 epoxiconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole] results in increased expression of DIABLO mRNA CTD PMID:29038839 fenthion decreases expression ISO RGD:1322044 6480464 Fenthion results in decreased expression of DIABLO mRNA CTD PMID:34813904 flutamide increases expression EXP 6480464 Flutamide results in increased expression of DIABLO mRNA CTD PMID:24136188 flutamide multiple interactions ISO RGD:1322044 6480464 CBL protein affects the reaction [Flutamide results in increased expression of DIABLO protein], Flutamide inhibits the reaction [CBL protein affects the expression of DIABLO protein] CTD PMID:16301331 flutamide increases expression ISO RGD:1322044 6480464 Flutamide results in increased expression of DIABLO protein CTD PMID:16301331 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of DIABLO mRNA CTD PMID:24793618 folic acid increases expression ISO RGD:1322044 6480464 Folic Acid results in increased expression of DIABLO mRNA, Folic Acid results in increased expression of DIABLO protein CTD PMID:12969128 folic acid multiple interactions ISO RGD:1322044 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of DIABLO mRNA] CTD PMID:22206623 fomepizole multiple interactions ISO RGD:1322044 6480464 Fomepizole inhibits the reaction [Acetaminophen affects the localization of DIABLO protein] CTD PMID:29739258 fumonisin B1 decreases expression ISO RGD:1322043 6480464 fumonisin B1 results in decreased expression of DIABLO protein CTD PMID:25800559 glucose increases expression ISO RGD:1322043 6480464 Glucose results in increased expression of DIABLO mRNA CTD PMID:33962019 glucose multiple interactions ISO RGD:1322043 6480464 [Glucose co-treated with Deferoxamine] results in increased expression of DIABLO mRNA, Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of DIABLO mRNA] CTD PMID:33962019 hydrogen peroxide multiple interactions EXP 6480464 Butylated Hydroxytoluene inhibits the reaction [Hydrogen Peroxide results in increased secretion of DIABLO protein] CTD PMID:14987999 hydrogen peroxide affects expression ISO RGD:1322043 6480464 Hydrogen Peroxide affects the expression of DIABLO protein CTD PMID:21179406 hydrogen peroxide increases secretion EXP 6480464 Hydrogen Peroxide results in increased secretion of DIABLO protein CTD PMID:14987999 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of DIABLO mRNA CTD PMID:21396975 ivermectin decreases expression ISO RGD:1322043 6480464 Ivermectin results in decreased expression of DIABLO protein CTD PMID:32959892 kainic acid increases expression EXP 6480464 Kainic Acid results in increased expression of DIABLO mRNA CTD PMID:19700661 lamivudine multiple interactions ISO RGD:1322044 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of DIABLO mRNA CTD PMID:18313992 LGK974 multiple interactions ISO RGD:1322043 6480464 LGK974 inhibits the reaction [Paraquat results in increased transport of DIABLO protein] CTD PMID:30205152 melatonin multiple interactions ISO RGD:1322043 6480464 [Doxorubicin co-treated with Melatonin] results in increased expression of DIABLO protein more ... CTD PMID:33507000 , PMID:33962019 melatonin increases expression ISO RGD:1322043 6480464 Melatonin results in increased expression of DIABLO mRNA, Melatonin results in increased expression of DIABLO protein CTD PMID:33507000 metformin multiple interactions ISO RGD:1322044 6480464 Metformin inhibits the reaction [Acetaminophen affects the localization of DIABLO protein] CTD PMID:27562556 minocycline decreases secretion ISO RGD:1322044 6480464 Minocycline results in decreased secretion of DIABLO protein CTD PMID:12930891 minocycline multiple interactions EXP 6480464 Minocycline inhibits the reaction [HTT protein mutant form results in increased secretion of DIABLO protein], Minocycline results in decreased secretion of and results in decreased expression of DIABLO protein CTD PMID:12930891 , PMID:14998631 mono(2-ethylhexyl) phthalate increases expression ISO RGD:1322043 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of DIABLO protein CTD PMID:24706461 mono(2-ethylhexyl) phthalate decreases expression ISO RGD:1322044 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of DIABLO mRNA CTD PMID:18755736 monosodium L-glutamate multiple interactions ISO RGD:1322044 6480464 [Fats more ... CTD PMID:23783067 morin increases expression ISO RGD:1322043 6480464 morin results in increased expression of DIABLO mRNA CTD PMID:28689916 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1322043 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cannabidiol promotes the reaction [DIABLO protein binds to XIAP protein]] CTD PMID:31699976 N-nitrosodiethylamine multiple interactions EXP 6480464 [3 more ... CTD PMID:17602206 , PMID:27048571 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of DIABLO mRNA CTD PMID:24136188 nitric oxide affects localization ISO RGD:1322043 6480464 Nitric Oxide affects the localization of DIABLO protein CTD PMID:15126337 ochratoxin A decreases expression ISO RGD:1322043 6480464 ochratoxin A results in decreased expression of DIABLO mRNA CTD PMID:17316727 p-menthan-3-ol increases expression ISO RGD:1322043 6480464 Menthol results in increased expression of DIABLO mRNA CTD PMID:26760959 paclitaxel multiple interactions ISO RGD:1322043 6480464 [resveratrol co-treated with Paclitaxel] affects the localization of DIABLO protein more ... CTD PMID:14749477 more ... paclitaxel affects localization ISO RGD:1322043 6480464 Paclitaxel affects the localization of DIABLO protein CTD PMID:18098270 paclitaxel increases expression ISO RGD:1322043 6480464 Paclitaxel results in increased expression of DIABLO protein CTD PMID:17701358 paracetamol affects expression ISO RGD:1322044 6480464 Acetaminophen affects the expression of DIABLO mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of DIABLO mRNA CTD PMID:33387578 paracetamol increases transport ISO RGD:1322044 6480464 Acetaminophen results in increased transport of DIABLO protein CTD PMID:28123000 paracetamol multiple interactions ISO RGD:1322044 6480464 [NQO1 gene mutant form results in increased susceptibility to Acetaminophen] which results in increased expression of DIABLO protein more ... CTD PMID:25224400 more ... paracetamol affects localization ISO RGD:1322044 6480464 Acetaminophen affects the localization of DIABLO protein CTD PMID:17906064 more ... paracetamol increases expression ISO RGD:1322043 6480464 Acetaminophen results in increased expression of DIABLO mRNA CTD PMID:25704631 paraquat multiple interactions EXP 6480464 Cyclosporine inhibits the reaction [Paraquat affects the localization of DIABLO protein] more ... CTD PMID:17936647 , PMID:25947082 paraquat affects localization ISO RGD:1322043 6480464 Paraquat affects the localization of DIABLO protein modified form CTD PMID:33383311 paraquat increases transport ISO RGD:1322043 6480464 Paraquat results in increased transport of DIABLO protein CTD PMID:30205152 paraquat multiple interactions ISO RGD:1322043 6480464 LGK974 inhibits the reaction [Paraquat results in increased transport of DIABLO protein], oren gedoku to inhibits the reaction [Paraquat affects the localization of DIABLO protein modified form] CTD PMID:30205152 , PMID:33383311 paraquat affects localization EXP 6480464 Paraquat affects the localization of DIABLO protein CTD PMID:22245251 , PMID:25947082 paraquat increases expression EXP 6480464 Paraquat results in increased expression of DIABLO protein CTD PMID:17936647 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of DIABLO mRNA CTD PMID:19162173 perfluorooctanoic acid increases expression ISO RGD:1322043 6480464 perfluorooctanoic acid results in increased expression of DIABLO protein CTD PMID:26879310 phenethyl isothiocyanate affects binding ISO RGD:1322043 6480464 DIABLO protein binds to phenethyl isothiocyanate CTD PMID:21838287 phenethyl isothiocyanate affects localization ISO RGD:1322043 6480464 phenethyl isothiocyanate affects the localization of DIABLO protein CTD PMID:16054126 phenethyl isothiocyanate multiple interactions ISO RGD:1322043 6480464 benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [phenethyl isothiocyanate affects the localization of DIABLO protein], Vitamin E inhibits the reaction [phenethyl isothiocyanate affects the localization of DIABLO protein] CTD PMID:16054126 phenobarbital multiple interactions EXP 6480464 [3 more ... CTD PMID:27048571 propylparaben increases expression ISO RGD:1322043 6480464 propylparaben results in increased expression of DIABLO mRNA CTD PMID:24481588 pterostilbene affects localization ISO RGD:1322043 6480464 pterostilbene affects the localization of DIABLO protein CTD PMID:22572619 pterostilbene increases expression ISO RGD:1322043 6480464 pterostilbene results in increased expression of DIABLO protein CTD PMID:22450950 , PMID:22572619 pyrroloquinoline quinone multiple interactions ISO RGD:1322043 6480464 PQQ Cofactor inhibits the reaction [Rotenone results in increased expression of DIABLO protein] CTD PMID:26276080 quercetin increases expression ISO RGD:1322043 6480464 Quercetin results in increased expression of DIABLO mRNA CTD PMID:20596804 quercetin affects localization ISO RGD:1322043 6480464 Quercetin affects the localization of DIABLO protein CTD PMID:23918355 quercetin increases localization ISO RGD:1322043 6480464 Quercetin results in increased localization of DIABLO protein CTD PMID:21138867 resveratrol affects localization ISO RGD:1322043 6480464 resveratrol affects the localization of DIABLO protein CTD PMID:17636462 resveratrol decreases expression ISO RGD:1322044 6480464 resveratrol results in decreased expression of DIABLO protein CTD PMID:17872969 resveratrol multiple interactions ISO RGD:1322043 6480464 [resveratrol co-treated with Paclitaxel] affects the localization of DIABLO protein CTD PMID:14749477 resveratrol increases expression ISO RGD:1322044 6480464 resveratrol results in increased expression of DIABLO protein CTD PMID:15837718 rotenone increases expression ISO RGD:1322043 6480464 Rotenone results in increased expression of DIABLO protein CTD PMID:26276080 rotenone multiple interactions ISO RGD:1322043 6480464 PQQ Cofactor inhibits the reaction [Rotenone results in increased expression of DIABLO protein] CTD PMID:26276080 SB 431542 multiple interactions ISO RGD:1322043 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DIABLO mRNA CTD PMID:27188386 simvastatin affects localization ISO RGD:1322043 6480464 Simvastatin affects the localization of DIABLO protein CTD PMID:20045437 simvastatin multiple interactions ISO RGD:1322043 6480464 DIABLO protein promotes the reaction [Simvastatin results in increased activity of CASP9 protein] CTD PMID:20045437 sirolimus multiple interactions ISO RGD:1322043 6480464 [7-hydroxystaurosporine co-treated with Sirolimus] affects the localization of DIABLO protein, Boc-D-FMK inhibits the reaction [[Sirolimus co-treated with 7-hydroxystaurosporine] affects the localization of DIABLO protein] CTD PMID:15767555 sodium dichromate increases transport ISO RGD:1322044 6480464 sodium bichromate results in increased transport of DIABLO protein CTD PMID:20298709 sorafenib multiple interactions ISO RGD:1322043 6480464 6-bromoindirubin-3'-oxime promotes the reaction [sorafenib affects the localization of DIABLO protein] more ... CTD PMID:17909059 , PMID:17991738 sorafenib affects localization ISO RGD:1322043 6480464 Sorafenib affects the localization of DIABLO protein CTD PMID:17991738 spermine affects localization ISO RGD:1322043 6480464 Spermine affects the localization of DIABLO protein CTD PMID:16151648 streptozocin multiple interactions ISO RGD:1322044 6480464 [Streptozocin co-treated with NQO1 protein mutant form] results in increased secretion of DIABLO protein CTD PMID:23458895 T-2 toxin increases expression ISO RGD:1322043 6480464 T-2 Toxin results in increased expression of DIABLO protein CTD PMID:34581912 thapsigargin affects response to substance ISO RGD:1322043 6480464 DIABLO protein affects the susceptibility to Thapsigargin CTD PMID:16382148 thapsigargin increases expression ISO RGD:1322043 6480464 Thapsigargin results in increased expression of DIABLO mRNA CTD PMID:22378314 thapsigargin affects localization ISO RGD:1322043 6480464 Thapsigargin affects the localization of DIABLO protein CTD PMID:15339911 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of DIABLO mRNA CTD PMID:23411599 trichostatin A decreases expression ISO RGD:1322043 6480464 trichostatin A results in decreased expression of DIABLO mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1322043 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DIABLO mRNA CTD PMID:27188386 tunicamycin increases expression ISO RGD:1322043 6480464 Tunicamycin results in increased expression of DIABLO mRNA CTD PMID:22378314 valproic acid affects expression ISO RGD:1322043 6480464 Valproic Acid affects the expression of DIABLO mRNA CTD PMID:25979313 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of DIABLO mRNA CTD PMID:23555832 vincristine decreases expression ISO RGD:1322043 6480464 Vincristine results in decreased expression of DIABLO mRNA CTD PMID:23649840 vitamin E multiple interactions ISO RGD:1322043 6480464 Vitamin E inhibits the reaction [cinnamaldehyde affects the localization of DIABLO protein], Vitamin E inhibits the reaction [phenethyl isothiocyanate affects the localization of DIABLO protein] CTD PMID:15566391 , PMID:16054126 vorinostat multiple interactions ISO RGD:1322043 6480464 [Bortezomib co-treated with vorinostat] affects the localization of DIABLO protein CTD PMID:12893773 zidovudine multiple interactions ISO RGD:1322044 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of DIABLO mRNA CTD PMID:18313992 zoledronic acid multiple interactions ISO RGD:1322043 6480464 [Tretinoin co-treated with zoledronic acid] results in decreased expression of DIABLO protein CTD PMID:20349282